Haukeland University Hospital
Bergen, 5021, Norway
NCT Number: NCT01750021
Obesity has become a global epidemic, and treating and preventing obesity appears to be one of the world's greatest challenges. The disorder is associated with a wide range of metabolic and hormonal changes, including the development of insulin resistance, changes in adipose tissue function, increased levels of blood lipids, cardiovascular disease and obesity induced fatty liver. Obesity is characterized by inflammation in adipose tissue, altered fat storage capacity and increased exchange of lipids between adipose tissue and blood, and increased secretion of cytokines from adipose tissue. Cytokines are believed to play a central role in the regulation of adipose tissue, the size of adipocytes and other metabolic conditions.
The hepatic synthesis of lipoproteins and interaction with adipose tissue is essential for the body's energy storages. The central role of the liver in energy supply, fat storage and normalization of blood values implies the importance of investigating the interaction between adipose tissue and liver to increase knowledge about the morbidity of obesity. Central obesity and insulin resistance are clear risk factors for the development of fatty liver, but the importance of diet is unclear. The common perception is that fatty liver condition can be improved by a reduction in dietary fat and cholesterols, but the relationship is unclear, and contradictory findings occur in epidemiological studies. It is therefore necessary to better understand the impact of the different macro-nutrients.
The purpose of this study is to determine whether two weight reducing diets with equal calorie levels that contain high or low fat differentially affects the adipose tissue function, distribution of body fat, as well as tissue, blood and urine levels of inflammatory markers, lipids, vitamins, hormones and other substances that may be related to metabolically health.
Looking for future studies?
Notify Me30 year–50 year
Male
Interventional
Not applicable
Bergen, 5021, Norway
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.
Exclusion criteria
.
70E% fat, 20E% protein, 10E% carbohydrates
20E% fat, 20E% protein, 60E% carbohydrates
Time frame: Baseline and 3 months and 6 months
CT, body composition, molecular analyses of adipose tissue
Time frame: Baseline and 3 months and 6 months
Molecular and biochemical analyses of tissue, blood and urine
Time frame: Baseline and 3 months and 6 months
Molecular and biochemical analyses of tissue, blood and urine
Time frame: Baseline and 3 months and 6 months
Molecular and biochemical analyses of tissue, blood and urine
Time frame: Baseline and 3 months and 6 months
Clinical and biochemical data
Time frame: Baseline and 3 months and 6 months
Evaluation of adipose tissue distribution by CT
Time frame: Baseline and 3 months and 6 months
Evaluation by CT
Haukeland University Hospital
Other
Comparison of Two Weight Reducing Diets in Obese Men
Acronym: FATFUNC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03548597
Body Weight, Digestive System Diseases
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT07701005
Body Weight, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05500586
Body Weight, Digestive System Diseases
Rochester, Minnesota, United States
View Trial Details